# The National Health Service (Cross-Border Healthcare and Miscellaneous Amendments etc.) (EU Exit) Regulations 2019, Regulation 4: The National Health Service (Wales) Act 2006

Extent: E+W+S+N.I.

(1) The NHS (Wales) Act is amended as follows.
(2) In section 46 (GMS contracts: prescription of drugs, etc)—
(a) in subsection (3), for “Community marketing authorization or United Kingdom” substitute “ UK ”;
(b) for subsection (4) substitute—
“(4) “UK marketing authorisation” has the meaning given by regulation 8(1) of the Human Medicines Regulations 2012 (S.I. 2012/1916).”.
(3) Omit the following provisions—
(a) section 6A (reimbursement of cost of services provided in another EEA state) ;
(b) section 6B (prior authorisation for the purposes of section 6A) ;
(c) section 6BA (reimbursement of cost of services provided in another EEA state where expenditure incurred on or after 25 October 2013) ;
(d) section 6BB (prior authorisation for the purposes of section 6BA) ;
(e) section 131(a)(ii) (payment of travelling expenses) ;
(f) the definition of “Regulation (EC) No. 883/2004” in section 206(1) (interpretation) except in so far as it relates to section 131(a)(iii).

---
Source: https://www.legislation.gov.uk/uksi/2019/777/regulation/4 (the official version)
Page: https://openlegislation.uk/national-health-service-cross-border-healthcare-and-miscellaneous-amendments-etc-eu-exit-regulations-2019/regulation-4
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

